enow.com Web Search

  1. Ads

    related to: rituxan for itp fda approved

Search results

  1. Results from the WOW.Com Content Network
  2. Rituximab - Wikipedia

    en.wikipedia.org/wiki/Rituximab

    Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. [18] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in children and adults, but not recommended in elderly patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura ...

  3. Immune thrombocytopenic purpura - Wikipedia

    en.wikipedia.org/.../Immune_thrombocytopenic_purpura

    [32] [33] Romiplostim was approved by the United States Food and Drug Administration (FDA) for long-term treatment of adult chronic ITP on August 22, 2008. [ 34 ] Eltrombopag (trade name Promacta in the US, Revolade in the EU) is an orally-administered agent with an effect similar to that of romiplostim.

  4. List of therapeutic monoclonal antibodies - Wikipedia

    en.wikipedia.org/wiki/List_of_therapeutic...

    This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.

  5. Does Medicare Part B Cover Rituxan? - AOL

    www.aol.com/does-medicare-part-b-cover-181651822...

    Rituxan (rituximab) is a type of antibody therapy (biologic) medication that may be used with or without chemotherapy. It destroys or helps your body destroy blood cells that contain cancer.

  6. Roche's Rituxan Gets Priority Review for Blood Disorder - AOL

    www.aol.com/news/roches-rituxan-gets-priority...

    Roche (RHHBY) gets Priority Review status from the FDA for Rituxan in children with two rare blood vessel disorders.

  7. Teva's Rituxan Biosimilar Gets FDA Nod in Non-Hodgkin ... - AOL

    www.aol.com/news/tevas-rituxan-biosimilar-gets...

    Teva (TEVA) and partner Celltrion get FDA nod for approval of their biosimilar to Roche's Rituxan in three Non-Hodgkin's lymphoma indications.

  8. Fostamatinib - Wikipedia

    en.wikipedia.org/wiki/Fostamatinib

    The U.S. Food and Drug Administration (FDA) approved fostamatinib based on evidence from two identical, double-blind, placebo-controlled clinical trials, FIT-1 (NCT02076399) and FIT-2 (NCT02076412) of 150 adults with persistent or chronic ITP who had an insufficient response to previous treatment, which included corticosteroids, immunoglobulins ...

  9. AbbVie Gets FDA Nod for Imbruvica+Rituxan in First-Line CLL - AOL

    www.aol.com/news/abbvie-gets-fda-nod-imbruvica...

    AbbVie's (ABBV) regulatory application seeking label expansion of Imbruvica as a first-line treatment for chronic lymphocytic leukemia in combination with Roche's Rituxan gets approval from the FDA.

  1. Ads

    related to: rituxan for itp fda approved